fluphenazine sulfoxide structure
|
Common Name | fluphenazine sulfoxide | ||
---|---|---|---|---|
CAS Number | 1674-76-6 | Molecular Weight | 453.52100 | |
Density | 1.43g/cm3 | Boiling Point | 615.4ºC at 760mmHg | |
Molecular Formula | C22H26F3N3O2S | Melting Point | 131-133ºC | |
MSDS | N/A | Flash Point | 326ºC |
Name | Fluphenazine Sulfoxide |
---|---|
Synonym | More Synonyms |
Density | 1.43g/cm3 |
---|---|
Boiling Point | 615.4ºC at 760mmHg |
Melting Point | 131-133ºC |
Molecular Formula | C22H26F3N3O2S |
Molecular Weight | 453.52100 |
Flash Point | 326ºC |
Exact Mass | 453.17000 |
PSA | 66.23000 |
LogP | 4.13010 |
Vapour Pressure | 5.28E-16mmHg at 25°C |
Index of Refraction | 1.654 |
Storage condition | 2-8°C |
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response.
Br. J. Psychiatry 158 , 658-65, (1991) The levels of fluphenazine and fluphenazine sulphoxide in schizophrenic patients who were randomly assigned to receive either 5 mg or 25 mg of fluphenazine decanoate every two weeks were monitored. Pa... |
|
Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
J. Psychiatry Neurosci. 19(4) , 254-64, (1994) This review covers some recent work on: 1. The effects of route of administration on the pharmacokinetics of fluphenazine and some of its metabolites; 2. The clinical pharmacokinetics of fluphenazine ... |
|
The sulfoxidation of fluphenazine in schizophrenic patients maintained on fluphenazine decanoate.
Psychopharmacology 93(3) , 369-73, (1987) Highly sensitive radioimmunoassays were applied to study the sulfoxidation of fluphenazine in 30 schizophrenic patients maintained on either 5 mg or 25 mg fluphenazine decanoate by intramuscular injec... |
Fluphenazine sulphoxide |
Fluphenazine sulfoxide |
2-[4-[3-[5-oxo-2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethanol |